Anavex Life Sciences Appoints Former FDA Officer as Senior Vice President for Nonclinical Development

Anavex Life Sciences Appoints Former FDA Officer as Senior Vice President for Nonclinical Development   NEW YORK – May 05, 2021 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and…